Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009

Anand A Dalal1, Fang Liu2, Aylin A Riedel21US Health Outcomes, GlaxoSmithKline, Research Triangle Park, Durham, NC; 2Health Economics and Outcomes Research, OptumInsight, Eden Prairie, MN, USABackground: Few estimates of health care costs related to chronic obstructive pulmonary disease (COPD) are a...

Full description

Bibliographic Details
Main Authors: Dalal AA, Liu F, Riedel AA
Format: Article
Language:English
Published: Dove Medical Press 2011-10-01
Series:International Journal of COPD
Online Access:http://www.dovepress.com/cost-trends-among-commercially-insured-and-medicare-advantage-insured--a8472